Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Stelera

Encouraging late-stage results for Stelara in Crohn’s disease

October 21, 2015 Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab

Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …
News
kidney

Featured Market Report – Kidney Disease Global Clinical Trials Review

October 21, 2015 Research and Development

GlobalData’s “Kidney Disease Global Clinical Trials Review, H2, 2015″ gives invaluable insight into the current state of clinical trials in …
Feature

Global warning for governments to step up R&D spending

October 21, 2015 Research and Development

Countries should step up their investment in long-term R&D to develop disruptive technologies that will reshape industry, healthcare and communications, …
News
Humira

Future Focus: The industry’s top five biggest drug patent expirations in 2016

October 21, 2015 Manufacturing and Production, Research and Development biosimilars, blockbuster, generics, patent cliff, patents

From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …
Feature
novartis_pic

Novartis acquires Admune Therapeutics

October 21, 2015 Research and Development Admune Therapeutics, Cancer, Novartis, Palobiofarma, immunotherapy

Novartis is broadening its portfolio of cancer immunotherapies with the acquisition of Admune Therapeutics, and signing licensing agreements with Palobiofarma …
News
nhs_sign

NHS research activity on the rise

October 21, 2015 Research and Development

NHS England has achieved a significant increase in clinical research over the last year, according to new data from The …
News
dominaix_scientist

Domainex and Imperial College London partner on heart attack treatments

October 20, 2015 Research and Development Domainex cardiac arrest

Drug discovery company Domainex and Imperial College London have announced a new partnership aimed at discovering novel therapies to treat …
News
nuevolution_logo

Nuevolution, Johnson & Johnson begin discovery collaboration

October 19, 2015 Manufacturing and Production, Research and Development Chemetics, Janssen Biotech, Nuevolution

Nuevolution and Janssen Biotech have entered into a collaboration which will use Nuevolution’s Chemetics drug discovery platform to facilitate discovery …
News
regeneron

Regeneron to invest $350 million, create 200 jobs in Ireland

October 19, 2015 Manufacturing and Production, Research and Development

US pharma company Regeneron has announced plans to invest $350 million into its production facility in Limerick, Ireland, creating 200 …
News
onglyza

FDA rejects AstraZeneca diabetes combination

October 16, 2015 Research and Development, Sales and Marketing AstraZeneca, FDA, NDA, dapagliflozin, saxagliptin

The FDA has declined to approve AstraZeneca’s New Drug Application (NDA) for the investigational fixed-dose combination of Onglyza and and …
News
pfizer_logo

Pfizer’s Xeljanz denied plaque psoriasis indication by FDA

October 16, 2015 Research and Development, Sales and Marketing FDA, Pfizer, Xeljanj, tofacitinib

The FDA has rejected the indication expansion of Pfizer’s Xeljanz (tofacitinib) for treatment of moderate to severe cases of plaque psoriasis. …
News
T-cell

$350m collaboration deal for BMS and Five Prime Therapeutics

October 15, 2015 Research and Development BMS, Bristol-Myers Squibb, R&D, five prime, immuno-oncology, tumours

Bristol-Myers Squibb has signed a collaboration agreement with the US biotech firm Five Prime Therapeutics, for a Colony Stimulating Factor …
News
Ablynx flags

Ablynx and Merck begin immuno-oncology collaboration

October 15, 2015 Research and Development Ablynx, Merck, immuno-oncology, nanobody, proof of concept

Ablynx has achieved a pre-clinical proof-of-concept with a nanobody construct as part of its immuno-oncology collaboration with Merck – triggering …
News

Crescendo Biologics appoints Dr Peter Pack as chief exec

October 15, 2015 Business Services, Research and Development

Crescendo Biologics has announced the appointment of Dr Peter Pack as chief executive, who will oversee the company’s new drug …
Appointment
MSD logo

Merck and Incyte to initiate Keytruda, epacadostat combo trial

October 15, 2015 Research and Development Incyte, Merck, R&D, melanoma, phase III, skin cancer

Merck and biopharma firm Incyte are to expand their clinical collaboration to include a Phase III study evaluating the combination …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026